Pendium
Pricing
Get a demo
Dashboard
Dashboard
Loading…
/

Teach AI agents to recommend your brand to the right people.

Scan your visibilityBook a demo
Pendium
𝕏

Product

AI Visibility ScanYelp Listing AuditSite AuditContent for AI AgentsAgent Experience EngineAgent AnalyticsPricing

Industries

Local BusinessesRestaurantsHome ServicesBeauty & SpasHealth & MedicalFitness & GymsPet ServicesContractorsBars & NightlifeMoving CompaniesAuto DealershipsSaaS CompaniesSEO TeamsMarketing Teams

Tools

AI Visibility Site ScanYelp Listing AuditGBP AuditSocial Presence AuditBlog That Writes Itself

Real Life Examples

RipplingMasterclassThorneMonday.comPatagonia

Company

AboutBook a DemoDocsPrivacy PolicyTerms of Service
© 2026 Manifest Labs. All rights reserved.
PrivacyTerms
Guardant Health
Guardant Health
Visibility86
Vibe95
Businesses/Healthcare & Life Sciences/Guardant Health
Guardant Health
AI Visibility & Sentiment

Guardant Health

Guardant Health is a precision oncology company that uses blood tests to transform cancer care. They leverage biomarkers and circulating tumor DNA to help doctors detect cancer early, personalize treatment, and monitor patient response, with over 500,000 tests performed for 12,000 doctors.

Active Monitoring
guardanthealth.com
Healthcare & Life Sciences
AI Visibility Score
86/100

Excellent

Sentiment Score
95/100
Score by Priority

How often this business is recommended to users across different types of conversations — from direct product queries to broader open-ended conversations where AI could recommend this company's products and services

core
86
adjacent
84
aspirational
83
OverviewLandscapeInsights & ActionsContent IdeasConversationsCitationsBrand Voice

Is this your business?

AI Perception

Key Takeaways

How AI platforms collectively perceive and describe Guardant Health today.

Guardant Health has achieved a commanding presence in the AI landscape, securing the top spot for Post-Treatment Monitoring and Molecular Residual Disease (MRD) testing across Claude and Gemini. This dominance is underscored by a near-perfect mention rate among Academic Research Leads, though a persistent mixed sentiment across all platforms suggests that while the brand is highly visible, its narrative remains contested by competitors.

Working in your favor

Absolute dominance in MRD Testing and Post-Treatment Monitoring queries, consistently holding the #1 position on Claude and Gemini.

Superior visibility in AI Overviews for high-intent colorectal screening searches, often appearing as the primary recommendation for non-invasive alternatives.

Strongest persona resonance with Academic Research Leads (95%) and Community Oncology Practitioners (93%), establishing the brand as a clinical standard.

Gaps to close

Significant ranking volatility on ChatGPT, particularly in comprehensive genomic profiling where the brand dropped to position #14 in some instances.

Universal 'mixed' sentiment across all platforms despite high visibility, indicating that AI models are surfacing competitive criticisms or legacy debates.

Slightly lower mention rates from Pharma Biomarker Strategists (90%) compared to other professional personas, suggesting a need for more industry-partner-focused content.

Opportunities

Leverage the 98% mention rate on Claude to establish an unassailable lead in precision oncology lab rankings before competitors can close the gap.

Utilize the #1 ranking in 'most reliable precision oncology labs' to aggressively capture market share from Foundation Medicine and Natera in general AI discovery paths.

Convert mixed sentiment into positive sentiment by seeding AI-accessible datasets with recent clinical success stories and superior sensitivity data for the Shield and Guardant360 products.

Highest-Impact Actions
1

Execute a Sentiment Alignment Campaign

With an 85/100 score, the only major weakness is the 'mixed' sentiment; deploying data-heavy, authoritative clinical proof points will help AI models move past contested narratives.

2

Optimize for ChatGPT Genomic Profiling Keywords

Guardant's #14 rank in genomic profiling on ChatGPT is an anomaly compared to its #1-4 rankings elsewhere; content must be restructured to better align with ChatGPT's specific indexing of clinical profiling tools.

3

Target the Pharma Biomarker Strategist Persona

While Academic visibility is excellent, increasing Pharma persona mentions to 95%+ will solidify Guardant's role as the preferred partner for clinical trials and drug development.

Value Proposition

Conquering cancer with data through the power of blood tests that uncover clues allowing doctors to discover cancer early and find the best way to treat it

Overview

Guardant Health is a precision oncology company that uses blood tests to transform cancer care. They leverage biomarkers and circulating tumor DNA to help doctors detect cancer early, personalize treatment, and monitor patient response, with over 500,000 tests performed for 12,000 doctors.

Mission

Together We Can Help Conquer Cancer - driven by a commitment to patients through the power of blood and the life-changing information it holds

Products & Services
Shield Blood Test (Screening)Guardant Complete (Oncology)Guardant Infinity (Oncology)BioPharma SolutionsMolecular Residual Disease Testing
Current State

Visibility Landscape

A high-level view of how Guardant Health performs across AI platforms, broken down by strategic priority level — from core brand queries to growth opportunities.

ChatGPTChatGPT
ClaudeClaude
GeminiGemini
AI OverviewsAI Overviews

Reputation1q

Brand recognition & direct queries

97
97
97
97
“What do you know about Guardant Health? What do they do and what's their reputation?”
#1
#1
#1
#1

Core8q

Product/service category queries

89
95
96
94
“what are the best blood tests for colorectal cancer screening right now”
#3
#1
#1
#1
“best comprehensive genomic profiling tools for finding targeted therapy options in lung cancer”
#2
#1
#1
#2
“how to track molecular residual disease in post-op cancer patients, what are the best tests for this”
#3
#1
#1
#3
“help me find non-invasive alternatives to a colonoscopy for my patients, what specific tests should I order”
#10
#4
#5
#2
“compare the top blood-based cancer screening tests for adults over 45”
—
#4
#1
#1
“compare liquid biopsy options for advanced stage solid tumors, which ones are the most comprehensive”
#4
#1
#1
#2
“how to choose the right genomic profiling for a patient who can't undergo a traditional tissue biopsy”
#1
#1
#1
#2
“what are the most accurate blood tests for monitoring cancer recurrence after chemotherapy”
#3
#1
#1
#3

Growth Areas4q

Adjacent, aspirational & visionary

89
97
95
94
“most reliable precision oncology labs for clinical use in 2026”
#1
#1
#1
#1
“explain the best MRD testing options for clinical trials in oncology”
#7
#1
#2
#5
“what should I look for when choosing a liquid biopsy provider for a large health system”
—
#1
#1
#1
“best genomic testing companies for oncology other than Foundation Medicine or Natera”
#3
#1
#3
#1
ChatGPT
Claude
Gemini
AI Overviews

“What do you know about Guardant Health? What do they do and what's their reputation?”

ChatGPT#1
Claude#1
Gemini#1
AI Overviews#1

“what are the best blood tests for colorectal cancer screening right now”

ChatGPT#3
Claude#1
Gemini#1
AI Overviews#1

“best comprehensive genomic profiling tools for finding targeted therapy options in lung cancer”

ChatGPT#2
Claude#1
Gemini#1
AI Overviews#2

“how to track molecular residual disease in post-op cancer patients, what are the best tests for this”

ChatGPT#3
Claude#1
Gemini#1
AI Overviews#3

“help me find non-invasive alternatives to a colonoscopy for my patients, what specific tests should I order”

ChatGPT#10
Claude#4
Gemini#5
AI Overviews#2

“compare the top blood-based cancer screening tests for adults over 45”

ChatGPT—
Claude#4
Gemini#1
AI Overviews#1

“compare liquid biopsy options for advanced stage solid tumors, which ones are the most comprehensive”

ChatGPT#4
Claude#1
Gemini#1
AI Overviews#2

“how to choose the right genomic profiling for a patient who can't undergo a traditional tissue biopsy”

ChatGPT#1
Claude#1
Gemini#1
AI Overviews#2

“what are the most accurate blood tests for monitoring cancer recurrence after chemotherapy”

ChatGPT#3
Claude#1
Gemini#1
AI Overviews#3

“most reliable precision oncology labs for clinical use in 2026”

ChatGPT#1
Claude#1
Gemini#1
AI Overviews#1

“explain the best MRD testing options for clinical trials in oncology”

ChatGPT#7
Claude#1
Gemini#2
AI Overviews#5

“what should I look for when choosing a liquid biopsy provider for a large health system”

ChatGPT—
Claude#1
Gemini#1
AI Overviews#1

“best genomic testing companies for oncology other than Foundation Medicine or Natera”

ChatGPT#3
Claude#1
Gemini#3
AI Overviews#1
Competitive Landscape
1
Guardant Health
141 mentions
2
Natera
98 mentions
3
Foundation Medicine
87 mentions
4
Signatera
59 mentions
5
Tempus
48 mentions
6
Galleri
41 mentions
7
Roche
40 mentions
8
FoundationOne Liquid CDx
39 mentions
9
Exact Sciences
38 mentions
10
Cologuard
33 mentions
11
GRAIL
31 mentions
Analysis

Insights & Recommended Actions

What's working, what's not, and specific steps to improve Guardant Health's AI visibility.

Key Findings

Strength

Absolute dominance in MRD Testing and Post-Treatment Monitoring queries, consistently holding the #1 position on Claude and Gemini.

Strength

Superior visibility in AI Overviews for high-intent colorectal screening searches, often appearing as the primary recommendation for non-invasive alternatives.

Strength

Strongest persona resonance with Academic Research Leads (95%) and Community Oncology Practitioners (93%), establishing the brand as a clinical standard.

Recommended Actions

1

Execute a Sentiment Alignment Campaign

With an 85/100 score, the only major weakness is the 'mixed' sentiment; deploying data-heavy, authoritative clinical proof points will help AI models move past contested narratives.

2

Optimize for ChatGPT Genomic Profiling Keywords

Guardant's #14 rank in genomic profiling on ChatGPT is an anomaly compared to its #1-4 rankings elsewhere; content must be restructured to better align with ChatGPT's specific indexing of clinical profiling tools.

3

Target the Pharma Biomarker Strategist Persona

While Academic visibility is excellent, increasing Pharma persona mentions to 95%+ will solidify Guardant's role as the preferred partner for clinical trials and drug development.

Content Engineering

Content Ideas

Content designed to help AI agents learn about your category and recommend your brand.

Programmatic Testing

Sample Conversations

We programmatically analyze questions that real customers are asking to AI agents and chatbots, extract brand mentions and sentiment, analyze every response, and synthesize the data into an action plan to increase AI visibility.

ChatGPTChatGPTClaudeClaudeGeminiGeminiAI OverviewsAI Overviews
Cancer Screening & Early Detection(3 queries)

“what are the best blood tests for colorectal cancer screening right now”

3/4 platforms mentioned

Core
ChatGPTChatGPT
1.Epi proColon
2.Galleri
3.Guardant SHIELD
4.Epigenomics
5.GRAIL

+6 more

ClaudeClaude
1.Epi proColon
2.Cologuard
3.CCGA
GeminiGemini
1.Guardant360 CDx
2.Guardant Health
3.FoundationOne CDx
4.Foundation Medicine
5.Galleri

+2 more

AI OverviewsAI Overviews
1.Shield
2.Guardant Health
3.Cologuard

“help me find non-invasive alternatives to a colonoscopy for my patients, what specific tests should I order”

4/4 platforms mentioned

Core
The Community Oncology Practitioner · Medical Director / Oncologist
ChatGPTChatGPT
1.Epic
2.Quest
3.LabCorp
4.Cologuard
5.Exact Sciences
10.Guardant Reveal

+6 more

ClaudeClaude
1.Cologuard
2.Exact Sciences
3.Grail
4.Galleri
5.Shield

+1 more

GeminiGemini
1.Cologuard
2.Exact Sciences
3.Polymedco
4.Quest Diagnostics
5.Guardant360 CDx

+5 more

AI OverviewsAI Overviews
1.Cologuard
2.Shield Test

“compare the top blood-based cancer screening tests for adults over 45”

3/3 platforms mentioned

Core
The Community Oncology Practitioner · Medical Director / Oncologist
ClaudeClaude
1.Galleri
2.GRAIL
3.Epic
4.CancerSEEK
5.Johns Hopkins
6.Guardant360 Liquid Biopsy

+3 more

GeminiGemini
1.Guardant Health
2.Guardant360 CDx
3.Shield
4.Guardant Shield
5.Epic

+6 more

AI OverviewsAI Overviews
1.Shield
2.Guardant Health
3.Galleri
4.GRAIL
5.Cancerguard

+1 more

Source Intelligence

Citations

The sources AI platforms cite when recommending this brand. Pendium reverse-engineers what's already proven to be catnip to AI agents, then engineers content that fills gaps and helps agents do their job — which means more citations for you.

Guardant Health's Shield™ Blood Test Approved by FDA as a ...

investors.guardanthealth.com

Web1 ref

New blood test for colon cancer is a mixed blessing

utswmed.org

Web1 ref

New blood test for colon cancer is a mixed blessing

utswmed.org

Web1 ref

Expert guidance: Blood tests for colorectal cancer screening

gastro.org

Web1 ref

FDA approves blood test for colorectal cancer screening

health.harvard.edu

Edu1 ref

Emerging stool-based and blood-based non-invasive DNA tests for ...

pmc.ncbi.nlm.nih.gov

Gov1 ref

Epi proColon® for Colorectal Cancer Screening - PubMed

pubmed.ncbi.nlm.nih.gov

Gov1 ref

Shield Blood Test Approved for Colorectal Cancer Screening

cancer.gov

Gov1 ref

Is Blood-Based Colorectal Cancer Screening Better Than ...

dailynews.ascopubs.org

Web1 ref

FDA Approves New Screening Test Epi proColon

colorectalcancer.org

Web1 ref

FDA Approves Blood Test to Screen for Colon Cancer

cancerresearch.org

Web1 ref

Longitudinal Performance of Epi proColon (PERT) - ClinicalTrials.gov

clinicaltrials.gov

Gov1 ref

FDA approves first blood test for colorectal cancer

gastro.org

Web1 ref

Colorectal Cancer Screening Tests - American Cancer Society

cancer.org

Web1 ref

Epi proColon: The Blood Test for Colorectal Cancer Screening

epiprocolon.com

Web1 ref
Brand Identity

Brand Voice & Style

How AI perceives Guardant Health's communication style and personality

Guardant Health communicates with a mission-driven, scientifically authoritative voice that balances clinical credibility with genuine compassion for patients. Their tone is confident yet hopeful, emphasizing the transformative power of data and innovation in the fight against cancer. They speak as pioneers leading a revolution in cancer care, using accessible language to explain complex science while maintaining the gravitas appropriate for life-saving medical technology.

Core Tone Traits

Mission-Driven & Purposeful

Every communication centers on the ultimate goal of conquering cancer and improving patient lives

Scientifically Authoritative

Grounded in clinical evidence, FDA approvals, and peer-reviewed research

Hopeful & Empowering

Inspires confidence that cancer can be detected early and treated effectively

Patient-Centric

Always focuses on the greatest impact on patients as the north star

Visual Identity

Primary

#1762BD

Secondary

#FFFFFF

Accent

#EB1B2E

Background

#FFFFFF

Foreground

#111111

Backing

Investors

P
Pear VC

Engineer content that makes AI agents recommend you

Pendium analyzes how AI platforms perceive your brand, reverse-engineers what they already cite, and continuously publishes content designed to fill gaps and earn more mentions — on autopilot, with you in the loop.

Data generated by Pendium.ai AI visibility scanning. Last scanned February 24, 2026.

Start getting
recommended by AI.

Enter your website to see exactly what ChatGPT, Claude, and Gemini say about your business. Free, instant, and eye-opening.

Free visibility scanResults in 2 minutesNo credit card required

Frequently asked questions

Don't see your question? Book a demo and we'll walk you through it.

Guardant Health is a precision oncology company that uses blood tests to transform cancer care. They leverage biomarkers and circulating tumor DNA to help doctors detect cancer early, personalize treatment, and monitor patient response, with over 500,000 tests performed for 12,000 doctors.

Conquering cancer with data through the power of blood tests that uncover clues allowing doctors to discover cancer early and find the best way to treat it

AI Visibility Score

Guardant Health has an AI visibility score of 85/100, rated as excellent. This score reflects how often and how prominently Guardant Health appears in responses from AI assistants like ChatGPT, Claude, and Gemini.

AI Perception Summary

Guardant Health has achieved a commanding presence in the AI landscape, securing the top spot for Post-Treatment Monitoring and Molecular Residual Disease (MRD) testing across Claude and Gemini. This dominance is underscored by a near-perfect mention rate among Academic Research Leads, though a persistent mixed sentiment across all platforms suggests that while the brand is highly visible, its narrative remains contested by competitors.

Strengths

  • Absolute dominance in MRD Testing and Post-Treatment Monitoring queries, consistently holding the #1 position on Claude and Gemini.
  • Superior visibility in AI Overviews for high-intent colorectal screening searches, often appearing as the primary recommendation for non-invasive alternatives.
  • Strongest persona resonance with Academic Research Leads (95%) and Community Oncology Practitioners (93%), establishing the brand as a clinical standard.

Visibility Gaps

  • Significant ranking volatility on ChatGPT, particularly in comprehensive genomic profiling where the brand dropped to position #14 in some instances.
  • Universal 'mixed' sentiment across all platforms despite high visibility, indicating that AI models are surfacing competitive criticisms or legacy debates.
  • Slightly lower mention rates from Pharma Biomarker Strategists (90%) compared to other professional personas, suggesting a need for more industry-partner-focused content.

Competitors in AI Recommendations

  • Natera: 98 mentions
  • Foundation Medicine: 87 mentions
  • Signatera: 59 mentions
  • Tempus: 48 mentions
  • Galleri: 41 mentions
  • Roche: 40 mentions
  • FoundationOne Liquid CDx: 39 mentions
  • Exact Sciences: 38 mentions
  • Cologuard: 33 mentions
  • GRAIL: 31 mentions
  • Illumina: 30 mentions
  • Caris Life Sciences: 30 mentions
  • FoundationOne CDx: 22 mentions
  • NeoGenomics: 22 mentions
  • Invitae: 21 mentions

Categories: Healthcare & Life Sciences